Google
 
Google

World Stem Cell Summit 2010

Wednesday, March 11, 2009

Bone Marrow Transplantation - Table of Contents alert Volume 43 Issue 5

BONE MARROW TRANSPLANTATION

March 2009 Volume 43 Number 5, pp 349 - 431
---------------------------------------------------------------------
Attending the EBMT Annual Meeting in Gothenburg this month?

Visit us at Booth #451 and pick up your complimentary copy of
Bone Marrow Transplantation
http://links.ealert.nature.com/ctt?kn=18&m=31892841&r=MTc1NjE0NTQ4OQS2&b=2&j=NDY0MzU2NjkS1&mt=1&rt=0
and other related journals from Nature Publishing Group.

We hope to see you there!

http://links.ealert.nature.com/ctt?kn=45&m=31892841&r=MTc1NjE0NTQ4OQS2&b=2&j=NDY0MzU2NjkS1&mt=1&rt=0

---------------------------------------------------------------------
A combined print and online personal subscription to this journal
gives you your own print copy and access to the entire website
including all back issues. Purchasing a subscription is easy; use
our online order form at
http://links.ealert.nature.com/ctt?kn=65&m=31892841&r=MTc1NjE0NTQ4OQS2&b=2&j=NDY0MzU2NjkS1&mt=1&rt=0
to start your subscription today.

----------------------
EDITORIAL
----------------------
To G or not to G: is this still a question in allogeneic transplantation?
N Hawk and H J Khoury
http://links.ealert.nature.com/ctt?kn=76&m=31892841&r=MTc1NjE0NTQ4OQS2&b=2&j=NDY0MzU2NjkS1&mt=1&rt=0

----------------------
REVIEW
----------------------
Filgrastim support in allogeneic HSCT for myeloid malignancies: a review
of the role of G-CSF and the implications for current practice
M Battiwalla and P L McCarthy
Abstract: http://links.ealert.nature.com/ctt?kn=73&m=31892841&r=MTc1NjE0NTQ4OQS2&b=2&j=NDY0MzU2NjkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=6&m=31892841&r=MTc1NjE0NTQ4OQS2&b=2&j=NDY0MzU2NjkS1&mt=1&rt=0

----------------------
ORIGINAL ARTICLES
----------------------
Regeneration, health status and quality of life after rhG-CSF-stimulated
stem cell collection in healthy donors: a cross-sectional study
G C Leitner, K Baumgartner, P Kalhs, D Biener, H T Greinix, P Hoecker and N Worel
Abstract: http://links.ealert.nature.com/ctt?kn=63&m=31892841&r=MTc1NjE0NTQ4OQS2&b=2&j=NDY0MzU2NjkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=13&m=31892841&r=MTc1NjE0NTQ4OQS2&b=2&j=NDY0MzU2NjkS1&mt=1&rt=0

Cord blood transplants supported by co-infusion of mobilized hematopoietic
stem cells from a third-party donor
G Bautista, J R Cabrera, C Regidor, R Fores, J A Garcia-Marco, E Ojeda,
I Sanjuan, E Ruiz, I Krsnik, B Navarro, S Gil, E Magro, A de Laiglesia,
R Gonzalo-Daganzo, T Martin-Donaire, M Rico, I Millan and M N Fernandez
Abstract: http://links.ealert.nature.com/ctt?kn=35&m=31892841&r=MTc1NjE0NTQ4OQS2&b=2&j=NDY0MzU2NjkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=26&m=31892841&r=MTc1NjE0NTQ4OQS2&b=2&j=NDY0MzU2NjkS1&mt=1&rt=0

Allogeneic blood SCT for children with Hurler's syndrome: results from the
German multicenter approach MPS-HCT 2005
M Sauer, B Meissner, D Fuchs, B Gruhn, H Kabisch, R Erttmann, M Suttorp,
A Beilken, T Luecke, K Welte, L Grigull and K W Sykora
Abstract: http://links.ealert.nature.com/ctt?kn=3&m=31892841&r=MTc1NjE0NTQ4OQS2&b=2&j=NDY0MzU2NjkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=2&m=31892841&r=MTc1NjE0NTQ4OQS2&b=2&j=NDY0MzU2NjkS1&mt=1&rt=0

Immunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20
(FBTA05), a trifunctional anti-CD3 [times] anti-CD20 antibody and donor
lymphocyte infusion
R Buhmann, B Simoes, M Stanglmaier, T Yang, M Faltin, D Bund, H Lindhofer and H-J Kolb
Abstract: http://links.ealert.nature.com/ctt?kn=11&m=31892841&r=MTc1NjE0NTQ4OQS2&b=2&j=NDY0MzU2NjkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=69&m=31892841&r=MTc1NjE0NTQ4OQS2&b=2&j=NDY0MzU2NjkS1&mt=1&rt=0

CD8+ T-cell responses to tumor-associated antigens correlate with superior
relapse-free survival after allo-SCT
M Kapp, S Stevanovic, K Fick, S M Tan, J Loeffler, A Opitz, T Tonn, G Stuhler,
H Einsele and G U Grigoleit
Abstract: http://links.ealert.nature.com/ctt?kn=36&m=31892841&r=MTc1NjE0NTQ4OQS2&b=2&j=NDY0MzU2NjkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=43&m=31892841&r=MTc1NjE0NTQ4OQS2&b=2&j=NDY0MzU2NjkS1&mt=1&rt=0

Predictors of mortality in patients undergoing autologous hematopoietic cell
transplantation admitted to the intensive care unit
M A Trinkaus, S E Lapinsky, M Crump, A Keating, D E Reece, C Chen, D C Hallett,
N Franke, A Winter and J R Mikhael
Abstract: http://links.ealert.nature.com/ctt?kn=60&m=31892841&r=MTc1NjE0NTQ4OQS2&b=2&j=NDY0MzU2NjkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=71&m=31892841&r=MTc1NjE0NTQ4OQS2&b=2&j=NDY0MzU2NjkS1&mt=1&rt=0

Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma
R L Olin, D T Vogl, D L Porter, S M Luger, S J Schuster, D E Tsai, D L Siegel,
R J Cook, P A Mangan, K Cunningham and E A Stadtmauer
Abstract: http://links.ealert.nature.com/ctt?kn=22&m=31892841&r=MTc1NjE0NTQ4OQS2&b=2&j=NDY0MzU2NjkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=30&m=31892841&r=MTc1NjE0NTQ4OQS2&b=2&j=NDY0MzU2NjkS1&mt=1&rt=0

Daclizumab as useful treatment in refractory acute GVHD: a paediatric experience
M Miano, D Cuzzubbo, P Terranova, S Giardino, E Lanino, G Morreale, E Castagnola,
G Dini and M Faraci
Abstract: http://links.ealert.nature.com/ctt?kn=58&m=31892841&r=MTc1NjE0NTQ4OQS2&b=2&j=NDY0MzU2NjkS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=70&m=31892841&r=MTc1NjE0NTQ4OQS2&b=2&j=NDY0MzU2NjkS1&mt=1&rt=0

----------------------
LETTER TO THE EDITOR
----------------------
Donor cell-derived myelodysplastic syndrome after cord blood transplantation
T Konuma, J Ooi, S Takahashi, A Tomonari, N Tsukada, S Kato, A Sato, F Monma,
E Hongo, K Uchimaru, A Tojo and S Asano
http://links.ealert.nature.com/ctt?kn=77&m=31892841&r=MTc1NjE0NTQ4OQS2&b=2&j=NDY0MzU2NjkS1&mt=1&rt=0

---------------------------------------------------------------------
Are you looking to reach a highly-skilled market for your recruitment
or classified ads?

Nature Publishing Group can offer you a portfolio of prestigious
journals that are targeted down to a specific sub-specialization.
With over 40 specialist titles to choose from, you can attract a
highly-skilled targeted audience within a number of scientific
disciplines. Both print and online options are available.

Contact your Naturejobs regional representative today:
W: http://links.ealert.nature.com/ctt?kn=51&m=31892841&r=MTc1NjE0NTQ4OQS2&b=2&j=NDY0MzU2NjkS1&mt=1&rt=0
E: naturejobs@nature.com

=====================================================================

You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=25&m=31892841&r=MTc1NjE0NTQ4OQS2&b=2&j=NDY0MzU2NjkS1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department:
registration@nature.com

For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com

For other enquiries, please contact customer feedback department:
feedback@nature.com

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne - San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© Copyright 2009 Nature Publishing Group

=====================================================================

Google

Any Comments ?.......

E-mail: manojhind2001us@gmail.com
Google
 

World Time